Abstract
S78 Rapid Versus Standard Infliximab and Infliximab Biosimilar Infusions in Pediatric Inflammatory Bowel Disease: Comparison of Adverse Reactions
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have